CEACAM5 and lung cancer: While upregulation of CEACAM5 and CXCL17 seems to have a biological explanation, the underlying mechanism of the lower systemic levels of both important cancer related receptor tyrosine kinases, VEGFR2 and ERBB3, in lung cancer patients, remains elusive.